focus -WSS

focus

author：focus 2025-08-23 04:56:52 - browse：8

CDC campus exterior -- first opinion coverage from STAT — ACIP, normally a 15-member panel, has eight vacancies, and four more coming soon. Why hasn't HHS signed off on the CDC's nominees? Adobe

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country.

The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year. The other seven members’ terms ended in July, though they were extended through the year because they had no replacements. There is no chairperson.

Four of the seven remaining members are due to finish their terms at the end of June, a cumulative exodus of expertise that will create what followers of the ACIP’s work believe is an unprecedented level of inexperience on the committee. Historically, three or four new members have been appointed to four-year terms every July, ensuring the roster always includes a mix of seasoned and new members.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： PEPFAR is under serious threat — and so is global health

WSS

Microsoft's Peter Lee: Generative AI could help doctors be more human

Acelyrin, a rare IPO success, stumbles in its first big test

$1 billion proposal to grow Boston, Massachusetts biotech

White House touts steps to stem shortages of cancer treatments

Immune cells and nerve overgrowth may explain recurring UTI pain

FDA approves updated Covid vaccines

leisure time

focus

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Telehealth for opioid use disorder is lifesaving

Sports medicine is finally prioritizing gender equality

Private equity could exacerbate cardiology's overuse problem, experts fear

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Families look for replacement for GSK asthma drug Flovent

Tori Bowie and the unacceptable rates of Black maternal death

Walmart eyes Medicare Advantage provider ChenMed

Tori Bowie and the unacceptable rates of Black maternal death

IRA could hurt research into orphan drugs for rare diseases

focus

Hospitals consider fixing cancer drug shortages on their own

New weight loss drugs vying to be the next Wegovy or Mounjaro

How medical schools plan to diversify without affirmative action

The untold story of TV’s first prescription drug ad

Families look for replacement for GSK asthma drug Flovent

State of the Union pitch: Bigger Medicare drug price negotiations

Wikipedia

entertainment

entertainment

hotspot